The Journal of Pharmacy Namira (JPN) considers research findings from fundamental research to clinical investigations as original articles, systematic reviews, meta-analyses, general reviews and mini-reviews. The Journal provides a platform for Pharmacists, Researchers, Academicians, and Practitioners who are highly motivated in contributing to the Pharmacy and Pharmaceutical Sciences disciplines.

The journal welcomes submissions from all over the world with no article processing charges.

The scope of this journal includes all areas related to pharmacy interest and not limited to drug development, pharmaceutical/medicinal chemistry, drug targeting, structure-based drug design, computational chemistry, genomics, proteomics, pharmacogenomics, bioinformatics, pharmacology, toxicology, pharmacokinetics, pharmaceutical analysis, pharmaceutical technology, drug delivery, drug formulation, biopharmaceutics, industrial pharmacy, pharmacognosy, natural product research, cosmeceutical, nutraceutical, pharmacy practice, pharmacoeconomics, pharmacoepidemiology, clinical pharmacy, hospital pharmacy, social and administrative pharmacy.

Publication Frequency

The Journal of Pharmacy published biannually (January and July) and this is an open-access Journal of Pharmacy Namira (JPN), STIKes Namira Madina.

Publication Ethics

These guidelines are consistent with the COPE Principles of Transparency, Best Practice Guidelines, and the COPE Code of Conduct (https://publicationethics.org).

We encourage the best standards of publication ethics and take all possible principles of transparency and measures against publication malpractice. The publisher plays its role of guardianship over all processes of publishing seriously, and we perform our ethical and other tasks.

Peer Review Process Statement

A manuscript undergoes a double-blind peer-review process. The section editors manage the reviews. Authors must upload revised versions and reply to the reviewer's comments.

The Journal of Pharmacy is committed to meeting and upholding standards of ethical behaviour at all stages of the publication process. A summary of our expectations of editors, peer-reviewers, and authors is stated below:

Editors' responsibilities

• To act in an objective, balanced, and fair way while carrying out expected duties, without discrimination on the grounds of gender, religious or political beliefs, or ethnic or geographical origin of the authors.
• To avoid any commercial influence and conflicts of interest, evaluate all submissions solely on academic and scientific merit.
• To address complaints of any nature and follow reasonable procedures according to the Journal's policies.
• To give authors a full opportunity to respond to complaints.
• To investigate a complaint regardless of the approval date of publication of an article.
• To document, compile, and file all complaints.

Reviewers' responsibilities

• To review the manuscript objectively and timely, inform the editor of a suitable decision and uphold the quality of articles published in the Journal.
• To maintain strict confidentiality of any information supplied to the reviewer in the editor or author's review process and ensure that the manuscript is for the reviewer's eyes only and no copies are transmitted or kept.
• To inform the editor of suspected plagiarism or absence of relevant published work which has not been cited. To avoid potential conflicts of interest between the author and the reviewer and inform the editor of all developments.

Authors' responsibilities

• To ensure they contributed significantly to the research, they cited all related references and acknowledged financial support from funding agencies.
• To maintain accurate records of data associated with their submitted manuscript and supply or provide access to these data on reasonable request.
• To confirm that the submitted manuscript is not under consideration or accepted for publication elsewhere.
• To acknowledge and cite sources whose contents overlap with the submitted paper.
• Provide the editor with a copy of any submitted manuscript(s) that might contain similar, closely related or overlapping content.
• To ensure that studies involving human or animal subjects conform to national, local and institutional laws and requirements.
• To confirm that approval has been sought and obtained where appropriate, get written permission from human subjects, and respect their privacy.
• To declare any potential conflicts of interest.
• To promptly inform the journal editor or publisher if a significant error in their publication is detected and submit an erratum, addendum, or corrigendum notice to be published or retract the paper altogether if necessary.
  
  

Usage of Generative AI and AI-assisted Technologies in Writing Policy

Where authors use AI and AI-assisted technologies in the writing process, these technologies should only be used to improve the readability and language of the work and not to replace key authoring tasks such as producing scientific, pedagogic, or medical insights, drawing scientific conclusions, or providing clinical recommendations.

Authors should disclose in their manuscript the use of AI and AI-assisted technologies and a statement will appear in the published work.

Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global knowledge exchange.

Archiving Policy

All published issues in the Journal of Pharmacy Namira (JPN) are archived in the PKP Preservation Networks.

Repository Policy

Authors are allowed to deposit submitted, accepted and published versions in an institutional or another repository of the author’s choice without embargo.

Copyright Notice